Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 28% ± 10% | |
GABAergic neuron | 3 studies | 28% ± 6% | |
glutamatergic neuron | 3 studies | 32% ± 9% | |
dendritic cell | 3 studies | 21% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3641.39 | 1445 / 1445 | 100% | 44.58 | 183 / 183 |
ovary | 100% | 4675.37 | 180 / 180 | 100% | 45.91 | 430 / 430 |
pancreas | 100% | 1961.97 | 328 / 328 | 100% | 27.79 | 178 / 178 |
skin | 100% | 3787.78 | 1809 / 1809 | 100% | 56.65 | 472 / 472 |
thymus | 100% | 4103.88 | 653 / 653 | 100% | 45.53 | 604 / 605 |
uterus | 100% | 4652.91 | 170 / 170 | 100% | 50.74 | 458 / 459 |
brain | 100% | 4866.51 | 2641 / 2642 | 100% | 55.68 | 703 / 705 |
prostate | 100% | 4678.14 | 245 / 245 | 100% | 45.26 | 500 / 502 |
adrenal gland | 100% | 3382.69 | 258 / 258 | 100% | 32.87 | 229 / 230 |
intestine | 100% | 3580.83 | 966 / 966 | 99% | 34.46 | 523 / 527 |
breast | 100% | 3500.76 | 459 / 459 | 99% | 42.94 | 1107 / 1118 |
kidney | 100% | 2732.20 | 89 / 89 | 99% | 30.45 | 892 / 901 |
stomach | 100% | 2798.38 | 359 / 359 | 99% | 34.57 | 282 / 286 |
bladder | 100% | 4007.19 | 21 / 21 | 98% | 41.50 | 495 / 504 |
liver | 100% | 1857.55 | 226 / 226 | 98% | 23.56 | 398 / 406 |
lung | 100% | 3087.58 | 577 / 578 | 98% | 37.69 | 1134 / 1155 |
adipose | 100% | 2994.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3509.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 60.20 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.21 | 29 / 29 |
muscle | 100% | 4804.27 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4310.29 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 47.17 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.06 | 1 / 1 |
heart | 99% | 2653.28 | 851 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 75% | 1931.14 | 696 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071391 | Biological process | cellular response to estrogen stimulus |
GO_0006364 | Biological process | rRNA processing |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005730 | Cellular component | nucleolus |
GO_0000791 | Cellular component | euchromatin |
GO_0005654 | Cellular component | nucleoplasm |
GO_0071339 | Cellular component | MLL1 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0032183 | Molecular function | SUMO binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PELP1 |
Protein name | Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) Proline, glutamate and leucine rich protein 1 Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3) |
Synonyms | HMX3 MNAR |
Description | FUNCTION: Coactivator of estrogen receptor-mediated transcription and a corepressor of other nuclear hormone receptors and sequence-specific transcription factors . Plays a role in estrogen receptor (ER) genomic activity when present in the nuclear compartment by activating the ER target genes in a hormonal stimulation dependent manner. Can facilitate ER non-genomic signaling via SRC and PI3K interaction in the cytosol. Plays a role in E2-mediated cell cycle progression by interacting with RB1. May have important functional implications in ER/growth factor cross-talk. Interacts with several growth factor signaling components including EGFR and HRS. Functions as the key stabilizing component of the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of ZNF148 and subsequent transactivation of ZNF148 target genes. Component of the PELP1 complex involved in the nucleolar steps of 28S rRNA maturation and the subsequent nucleoplasmic transit of the pre-60S ribosomal subunit. Regulates pre-60S association of the critical remodeling factor MDN1 . May promote tumorigenesis via its interaction with and modulation of several oncogenes including SRC, PI3K, STAT3 and EGFR. Plays a role in cancer cell metastasis via its ability to modulate E2-mediated cytoskeleton changes and cell migration via its interaction with SRC and PI3K. . |
Accessions | I3L4P1 ENST00000575101.1 I3L1P4 ENST00000575329.5 Q8IZL8 I3L445 E7EV54 I3L4M7 ENST00000572293.7 ENST00000574876.5 C9JFV4 ENST00000436683.6 ENST00000570387.5 ENST00000570571.5 ENST00000301396.8 |